Spectral AI Inc. (NASDAQ:MDAI) revealed Monday the performance results of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI, which focuses on medical ...
MDAI READ THE FULL MDAI RESEARCH REPORT Spectral AI, Inc. (NASDAQ: MDAI) reported first quarter 2026 results on May 12 th ...
DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI, Inc. (NASDAQ: MDAI) reported 2025 results on March 24 th after the market close. Highlights since the company’s third quarter release include the elevation of Vincent Capone to Chief ...
Multispectral Imaging and Assessment of Burns Healing Potential: A Prospective Real-World Study to assess the DeepView Snapshot Imaging Platform – Sam Snelling, North Bristol NHS Trust, Bristol, ...
DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year over year to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results